OptiBiotix Health Plc (AIM:OPTI)

Market Cap	12.14M
Revenue (ttm)	870.00K
Net Income (ttm)	-1.81M
Shares Out	103.30M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	249,036
Average Volume	331,255
Open	11.61
Previous Close	12.00
Day's Range	11.50 - 12.00
52-Week Range	10.00 - 24.50
Beta	1.70
RSI	52.48
Earnings Date	Sep 26, 2025

About OptiBiotix Health

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its products include Slimbiome, which offers a scientifically supported, non-pharmaceutical approach to reduce hunger and cravings; C...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 10
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: OPTI

Financial Performance

In 2024, OptiBiotix Health's revenue was 870,000, an increase of 35.09% compared to the previous year's 644,000. Losses were -1.81 million, -11.48% less than in 2023.